The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders
Background: The etiology of autoimmune diseases is not fully clarified and the mechanisms underlying their initiation and progression are still obscure. It is becoming clear that in a genetic susceptible individual an environmental trigger such as infectious agent in general and viruses in particula...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2008
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23356
- Acceso en línea:
- https://doi.org/10.1016/j.autrev.2008.06.008
https://repository.urosario.edu.co/handle/10336/23356
- Palabra clave:
- Hepatitis B core antibody
Immunoglobulin G
Anamnesis
Antibody blood level
Autoimmune disease
Blood sampling
Cohort analysis
Controlled study
Hepatitis B
Hepatitis B virus
Human
Insulin dependent diabetes mellitus
Major clinical study
Multiple sclerosis
Review
Rheumatoid arthritis
Screening test
Sjoegren syndrome
Systemic lupus erythematosus
Autoimmune Diseases
Hepatitis B
Hepatitis B Antibodies
Hepatitis B virus
Humans
Autoimmunity
Hepatitis B core antibody (hbcab)
Hepatitis B virus (HBV)
Multiple sclerosis (MS)
Rheumatoid arthritis (RA)
Sjogren's syndrome (SS)
Systemic lupus erythematosus (SLE)
Type 1 diabetes (T1D)
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_07c95f3210669cc907b2c9feed0a367a |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/23356 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
736bd165-bcee-4f3a-944f-f1fd9b00fcb1194747786007c2e984e-2eeb-494c-bedf-f2c894bf2f2bf5852284-d997-45c7-8fdb-57edaa4a6584bad32f53-051a-4e09-8327-d28bdada4183c8824fac-5fca-48bd-acff-0f2116edaaa7ef6fa7cf-59f5-4c86-bc53-d389160d7ddf2020-05-26T00:01:22Z2020-05-26T00:01:22Z2008Background: The etiology of autoimmune diseases is not fully clarified and the mechanisms underlying their initiation and progression are still obscure. It is becoming clear that in a genetic susceptible individual an environmental trigger such as infectious agent in general and viruses in particular could initiate the development of an autoimmune disease. Hepatitis B virus (HBV) is notorious in its association with diverse autoimmune diseases. Therefore, we aimed to determine the presence of hepatitis B core antibody (HBcAb), a seromarker for past or present infection with HBV, in a large number of sera collected from patients with different autoimmune diseases. Methods: A cohort of 675 sera samples of 5 different autoimmune diseases and healthy donors were screened for evidence of a prior infection with HBV. All samples were tested for hepatitis B core antibody (IgG) using the Monolisa anti-HBc PLUS commercial kit (Bio-Rad, Hercules, San Francisco, USA). Results: Lower percentage of HBcAb was found in sera of the autoimmune diseases when compared to normal controls. Fifteen (10.7%) from 140 normal controls were found positive for the presence of HBcAb. Two (2%) out of 98 multiple sclerosis (MS) sera were positive for the presence of HBcAb (OR: 0.17, 95%CI: 0.03-0.77, p = 0.01), 3 (2.5%) out of 117 systemic lupus erythematosus (SLE) sera (OR: 0.2, 95%CI: 0.06-0.77, p = 0.01), 4 (4.5%) out of 89 type 1 diabetes (T1D), 5 (6.1%) from 82 Sjogren's syndrome (SS) sera and 12 (8%) from 149 rheumatoid arthritis (RA) sera were positive for the presence of HBcAb. Conclusions: Our data divulge an unexpected low percentage of antibodies to HBcAg in patients with SLE, MS and T1D in comparison to healthy matched donors. This finding may raise a protective role to HBV in some autoimmune diseases i.e. hygiene theory. © 2008 Elsevier B.V. All rights reserved.application/pdfhttps://doi.org/10.1016/j.autrev.2008.06.00815689972https://repository.urosario.edu.co/handle/10336/23356eng625No. 8621Autoimmunity ReviewsVol. 7Autoimmunity Reviews, ISSN:15689972, Vol.7, No.8 (2008); pp. 621-625https://www.scopus.com/inward/record.uri?eid=2-s2.0-50949126626&doi=10.1016%2fj.autrev.2008.06.008&partnerID=40&md5=3f5a41252f3bec9c3ffb3ce8809df214Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURHepatitis B core antibodyImmunoglobulin GAnamnesisAntibody blood levelAutoimmune diseaseBlood samplingCohort analysisControlled studyHepatitis BHepatitis B virusHumanInsulin dependent diabetes mellitusMajor clinical studyMultiple sclerosisReviewRheumatoid arthritisScreening testSjoegren syndromeSystemic lupus erythematosusAutoimmune DiseasesHepatitis BHepatitis B AntibodiesHepatitis B virusHumansAutoimmunityHepatitis B core antibody (hbcab)Hepatitis B virus (HBV)Multiple sclerosis (MS)Rheumatoid arthritis (RA)Sjogren's syndrome (SS)Systemic lupus erythematosus (SLE)Type 1 diabetes (T1D)The putative protective role of hepatitis B virus (HBV) infection from autoimmune disordersarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Ram, MayaAnaya, Juan-ManuelBarzilai, OriIzhaky, DavidKatz, Bat-sheva PoratBlank, MiriShoenfeld, Yehuda10336/23356oai:repository.urosario.edu.co:10336/233562022-05-02 07:37:13.801338https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders |
title |
The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders |
spellingShingle |
The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders Hepatitis B core antibody Immunoglobulin G Anamnesis Antibody blood level Autoimmune disease Blood sampling Cohort analysis Controlled study Hepatitis B Hepatitis B virus Human Insulin dependent diabetes mellitus Major clinical study Multiple sclerosis Review Rheumatoid arthritis Screening test Sjoegren syndrome Systemic lupus erythematosus Autoimmune Diseases Hepatitis B Hepatitis B Antibodies Hepatitis B virus Humans Autoimmunity Hepatitis B core antibody (hbcab) Hepatitis B virus (HBV) Multiple sclerosis (MS) Rheumatoid arthritis (RA) Sjogren's syndrome (SS) Systemic lupus erythematosus (SLE) Type 1 diabetes (T1D) |
title_short |
The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders |
title_full |
The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders |
title_fullStr |
The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders |
title_full_unstemmed |
The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders |
title_sort |
The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders |
dc.subject.keyword.spa.fl_str_mv |
Hepatitis B core antibody Immunoglobulin G Anamnesis Antibody blood level Autoimmune disease Blood sampling Cohort analysis Controlled study Hepatitis B Hepatitis B virus Human Insulin dependent diabetes mellitus Major clinical study Multiple sclerosis Review Rheumatoid arthritis Screening test Sjoegren syndrome Systemic lupus erythematosus Autoimmune Diseases Hepatitis B Hepatitis B Antibodies Hepatitis B virus Humans Autoimmunity Hepatitis B core antibody (hbcab) Hepatitis B virus (HBV) Multiple sclerosis (MS) Rheumatoid arthritis (RA) Sjogren's syndrome (SS) Systemic lupus erythematosus (SLE) Type 1 diabetes (T1D) |
topic |
Hepatitis B core antibody Immunoglobulin G Anamnesis Antibody blood level Autoimmune disease Blood sampling Cohort analysis Controlled study Hepatitis B Hepatitis B virus Human Insulin dependent diabetes mellitus Major clinical study Multiple sclerosis Review Rheumatoid arthritis Screening test Sjoegren syndrome Systemic lupus erythematosus Autoimmune Diseases Hepatitis B Hepatitis B Antibodies Hepatitis B virus Humans Autoimmunity Hepatitis B core antibody (hbcab) Hepatitis B virus (HBV) Multiple sclerosis (MS) Rheumatoid arthritis (RA) Sjogren's syndrome (SS) Systemic lupus erythematosus (SLE) Type 1 diabetes (T1D) |
description |
Background: The etiology of autoimmune diseases is not fully clarified and the mechanisms underlying their initiation and progression are still obscure. It is becoming clear that in a genetic susceptible individual an environmental trigger such as infectious agent in general and viruses in particular could initiate the development of an autoimmune disease. Hepatitis B virus (HBV) is notorious in its association with diverse autoimmune diseases. Therefore, we aimed to determine the presence of hepatitis B core antibody (HBcAb), a seromarker for past or present infection with HBV, in a large number of sera collected from patients with different autoimmune diseases. Methods: A cohort of 675 sera samples of 5 different autoimmune diseases and healthy donors were screened for evidence of a prior infection with HBV. All samples were tested for hepatitis B core antibody (IgG) using the Monolisa anti-HBc PLUS commercial kit (Bio-Rad, Hercules, San Francisco, USA). Results: Lower percentage of HBcAb was found in sera of the autoimmune diseases when compared to normal controls. Fifteen (10.7%) from 140 normal controls were found positive for the presence of HBcAb. Two (2%) out of 98 multiple sclerosis (MS) sera were positive for the presence of HBcAb (OR: 0.17, 95%CI: 0.03-0.77, p = 0.01), 3 (2.5%) out of 117 systemic lupus erythematosus (SLE) sera (OR: 0.2, 95%CI: 0.06-0.77, p = 0.01), 4 (4.5%) out of 89 type 1 diabetes (T1D), 5 (6.1%) from 82 Sjogren's syndrome (SS) sera and 12 (8%) from 149 rheumatoid arthritis (RA) sera were positive for the presence of HBcAb. Conclusions: Our data divulge an unexpected low percentage of antibodies to HBcAg in patients with SLE, MS and T1D in comparison to healthy matched donors. This finding may raise a protective role to HBV in some autoimmune diseases i.e. hygiene theory. © 2008 Elsevier B.V. All rights reserved. |
publishDate |
2008 |
dc.date.created.spa.fl_str_mv |
2008 |
dc.date.accessioned.none.fl_str_mv |
2020-05-26T00:01:22Z |
dc.date.available.none.fl_str_mv |
2020-05-26T00:01:22Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1016/j.autrev.2008.06.008 |
dc.identifier.issn.none.fl_str_mv |
15689972 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/23356 |
url |
https://doi.org/10.1016/j.autrev.2008.06.008 https://repository.urosario.edu.co/handle/10336/23356 |
identifier_str_mv |
15689972 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
625 |
dc.relation.citationIssue.none.fl_str_mv |
No. 8 |
dc.relation.citationStartPage.none.fl_str_mv |
621 |
dc.relation.citationTitle.none.fl_str_mv |
Autoimmunity Reviews |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 7 |
dc.relation.ispartof.spa.fl_str_mv |
Autoimmunity Reviews, ISSN:15689972, Vol.7, No.8 (2008); pp. 621-625 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-50949126626&doi=10.1016%2fj.autrev.2008.06.008&partnerID=40&md5=3f5a41252f3bec9c3ffb3ce8809df214 |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167513925156864 |